faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.
faCellitate has raised $3.7M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
faCellitate's investors include HTGF (High-Tech Gruenderfonds), R3, Arve Capital, Chemovator, SARSTEDT.
faCellitate is headquartered in Mannheim, Germany.
faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.
faCellitate is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"faCellitate — Funding & Investors." VCBacked, September 7, 2022, https://www.vcbacked.co/company/facellitate. Accessed September 30, 2026.
VCBacked. (2022). faCellitate — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/facellitate
{{cite web |title=faCellitate — Funding & Investors |url=https://www.vcbacked.co/company/facellitate |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated